Get started
Author

Thor‐Henrik Brodtkorb

Observed names: Brodtkorb T-h, Brodtkorb, Thor-Henrik, T. Brodtkorb, T. H. Brodtkorb, T. Henrik-Brodtkorb, T.-H. Brodtkorb, T.H. Brodtkorb, TH Brodtkorb, Th. -H. Brodtkorb, Thor Henrik Brodtkorb, Thor-Henrik Brodtkorb, Thor-henrik Brodtkorb, T‐H Brodtkorb
Observed institutions: Linköping University, RTI International, Sahlgrenska University Hospital, RTI Health Solutions, University of Gothenburg, Jönköping University
ORCID: 0000-0002-9899-233X
Observed ORCID: 0000-0002-9899-233X
OpenAlex ID: A5018257301
Cost-Effectiveness of C-Leg Compared With Non–Microprocessor-Controlled Knees: A Modeling Approach
2008 · Thor-Henrik Brodtkorb, Martin Henriksson, et al. · Archives of Physical Medicine and Rehabilitation · 71
Considerations for developing an evidenced-based practice in orthotics and prosthetics
2008 · N. Ramstrand, T.-H. Brodtkorb · Prosthetics and Orthotics International · 52
Patients with unilateral transfemoral amputation treated with a percutaneous osseointegrated prosthesis
2018 · E. Hansson, K. Hagberg, et al. · The Bone & Joint Journal · 48
PDF
The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model
2014 · Philippe Laramée, Thor-Henrik Brodtkorb, et al. · BMJ Open · 47
PDF
Budget-Impact Analysis of Health Care Interventions
2017 · Josephine Mauskopf, Stephanie R. Earnshaw, et al. · Springer eBooks · 41
The long‐term cost‐effectiveness of fetal monitoring during labour: a comparison of cardiotocography complemented with ST analysis versus cardiotocography alone
2008 · E Heintz, T‐H Brodtkorb, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 37
PDF
Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
2020 · Ben Rothwell, Christopher Kiff, et al. · PharmacoEconomics - Open · 24
PDF
Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review
2021 · James Brockbank, Taryn Krause, et al. · Health and Quality of Life Outcomes · 20
PDF
Modular socket system versus traditionally laminated socket
2011 · Elna Normann, Anna Olsson, et al. · Prosthetics and Orthotics International · 19
The influence of metatarsal support height and longitudinal axis position on plantar foot loading
2007 · Thor-Henrik Brodtkorb, Géza F. Kogler, et al. · Clinical Biomechanics · 18
Relationship between modeling technique and reported outcomes: case studies in models for the treatment of schizophrenia
2014 · Birgitta von Schéele, Josephine Mauskopf, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 13
The Cost-Effectiveness of the Integration of Nalmefene within the UK Healthcare System Treatment Pathway for Alcohol Dependence
2016 · Philippe Laramée, Melissa Bell, et al. · Alcohol and Alcoholism · 12
The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective
2016 · Thor-Henrik Brodtkorb, Melissa Bell, et al. · CNS Drugs · 11
Value of information: interim analysis of a randomized, controlled trial of goal-directed hemodynamic treatment for aged patients
2013 · Erzsebet Bartha, Thomas Davidson, et al. · Trials · 11
PDF
Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States
2020 · Xiaoying Jia, Yang Zhao, et al. · Journal of Dermatological Treatment · 10
PDF
Comparative cost-effectiveness of tildrakizumab and other commonly used treatments for moderate-to-severe psoriasis
2020 · Jashin J. Wu, Xiaoying Jia, et al. · Journal of Dermatological Treatment · 10
PDF
Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspective
2024 · Thor-Henrik Brodtkorb, Christopher Knight, et al. · Journal of Medical Economics · 8
PDF
A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence
2016 · Philippe Laramée, Aurélie Millier, et al. · Clinical Drug Investigation · 8
EE228 A Review of Treatment Effect Waning Methods for Immuno-Oncology Therapies in National Institute for Health and Care Excellence Technology Appraisals
2022 · F Kamgar, S Ho, et al. · Value in Health · 6
PDF
Cost-effectiveness analysis of health technologies when evidence is scarce
2010 · Thor‐Henrik Brodtkorb · DiVA (Linkoping University) · 5
Cost‐effectiveness of clean air administered to the breathing zone in allergic asthma
2009 · Thor‐Henrik Brodtkorb, Olle Zetterström, et al. · The Clinical Respiratory Journal · 5
The Budget Impact of Introducing Tildrakizumab to a United States Health Plan for Managing Moderate-to-Severe Plaque Psoriasis
2020 · Justin Carrico, Yang Zhao, et al. · PharmacoEconomics - Open · 3
PDF
Challenges, considerations, and approaches for developing a cost-effectiveness model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a spotlight on nivolumab versus placebo
2024 · Siguroli Teitsson, Thor-Henrik Brodtkorb, et al. · Journal of Medical Economics · 2
PDF
EE469 A Review of Cure Assumptions Implemented in Early-Stage Oncology NICE Appraisals
2022 · H Hancock, J Brockbank, et al. · Value in Health · 2
Patient-reported benefits of bone-anchored transfemoral prostheses as assessed by MedTech20: A general outcome measure for medical products
2021 · Kerstin Hagberg, Thor-Henrik Brodtkorb · Prosthetics and Orthotics International · 2
Works count: 70
Citation count: 495
H-index: 12
I10-index: 16
Year
Topic
Type